Tumor Necrosis Factor: How to Make a Killer Molecule Tumor-Specific?

E-ISSN： 1873-5576|5|6|381-392

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.5, Iss.6, 2005-09, pp. : 381-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor -stimulated vascular endothelial cells

By Ishizuka T. Takamizawa-Matsumoto M. Suzuki K. Kurita A.

European Journal of Pharmacology, Vol. 369, Iss. 2, 1999-03 ,pp. : 237-245

Elsevier

Access to resources Recommend Favorite

Tumor necrosis factor as a therapeutic target of rheumatologic disease

By Ackermann Christoph Kavanaugh Arthur

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 11, 2007-11 ,pp. : 1369-1384

Informa Healthcare

Access to resources Recommend Favorite

Targeting Tumor Necrosis Factor- in the Therapy of Psoriasis

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 2, 2004-06 ,pp. : 175-183

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis

By Ranganathan Prabha

Pharmacogenomics, Vol. 6, Iss. 5, 2005-07 ,pp. : 481-490

Future Medicine

Access to resources Recommend Favorite

Tumor Necrosis Factor Inhibitors as Therapeutic Choice in Psoriasis

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 8, Iss. 1, 2009-03 ,pp. : 47-50

Bentham Science Publishers

Access to resources Recommend Favorite